Yijun Wu

9PUBLICATIONS
44CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Context learningRadiation therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2024
Real-World Survival Comparisons Between Radiotherapy and Surgery for Metachronous Second Primary Lung Cancer and Predictions of Lung Cancer-Specific Outcomes Using Machine Learning: Population-Based Study.

Yue Zheng, Ailin Zhao, Yuqi Yang

|Jun 10, 2024
CDK4/6 inhibitor abemaciclib combined with low-dose radiotherapy enhances the anti-tumor immune response to PD-1 blockade by inflaming the tumor microenvironment in Rb-deficient small cell lung cancer.

Laduona Wang, Yijun Wu, Kai Kang

|Apr 10, 2024
Embracing ChatGPT for Medical Education: Exploring Its Impact on Doctors and Medical Students.

Yijun Wu, Yue Zheng, Baijie Feng

|Aug 15, 2023
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients.

Xiaojuan Zhou, Laiyan Zhou, Zhuoran Yao

|Jan 21, 2023
Single-Cell Profiling Comparisons of Tumor Microenvironment between Primary Advanced Lung Adenocarcinomas and Brain Metastases and Machine Learning Algorithms in Predicting Immunotherapeutic Responses.

Yijun Wu, Kai Kang, Chang Han

|Jan 12, 2022
Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.

Yijun Wu, Yunlong Li, Chang Han

Pageof 2

Frequent Collaborators

5 joint publications

Kai Kang

2 joint publications

Ailin Zhao

2 joint publications

Yuqi Yang

2 joint publications

Zhuoran Yao